Nebenwirkungen · Dacogen
Dacogen 50 mg powder for concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 7–8
HOS-218007 · Präparat HOS-216153
7 Differentiation syndrome Cases of differentiation syndrome (also known as retinoic acid syndrome) have been reported in patients receiving decitabine. Differentiation syndrome may be fatal and symptoms and clinical findings include respiratory distress, pulmonary infiltrates, fever, rash, pulmonary oedema, peripheral oedema, rapid weight gain, pleural effusions, pericardial effusions, hypotension and renal dysfunction. Differentiation syndrome may occur with or without concomitant leucocytosis. Capillary leak syndrome and coagulopathy can also occur (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-10-02T12:30:00Z · SHA-256 516610473991e1f96619ec384abed306afe6a8e153f1cb00e60fc72274197f0f · Passage 312de913950981581e5150ca2f217f0f4f264fb1d344e6d4bf66714b56c495a3 · Zeichen 7857–8434 im Abschnitt